Parallel Bio
YC S21 · Active · Using the immune system to cure disease
Competitors
| Company | Category | Status | Program |
|---|---|---|---|
 CellTypeShared: human biology, drug discovery, biologicalActiveAI | AI | Active | YCW26 |
 Numerion LabsShared: drug discovery, biotech, biologyActiveAI | AI | Active | YCW15 |
 Rosebud BiosciencesShared: drug development, drug discovery, biotechActiveAI | AI | Active | YCW22 |
 Output BiosciencesShared: ai-powered drug discovery, biotech, biologyActiveAI | AI | Active | YCS21 |
 Harmonic DiscoveryShared: drug discovery, biotech, diseaseActiveAI | AI | Active | YCS21 |
Adjacent
| Company | Category | Status | Program |
|---|---|---|---|
 SFA TherapeuticsShared: immune system, ai-powered drug discovery, biotechActiveAI | AI | Active | YCS21 |
 BiocartesianShared: disease biology, biotech, cureActiveOther | Other | Active | YCS24 |
 Tamarind BioShared: drug discovery, biotech, biologyActiveAI | AI | Active | YCW24 |
 NanograbShared: drug discovery, biotech, computationalActiveAI | AI | Active | YCS23 |
 Ditto BiosciencesShared: immune system, biology, diseaseActiveAI | AI | Active | YCW26 |
Also from S21 in AI
All of S21
About Parallel Bio
Parallel Bio is pioneering human-first drug discovery by creating the first map of human biology. Using groundbreaking biological and computational tools that track real clinical outcomes, the company generates data that enable earlier, more reliable decisions about disease biology and drug development. Parallel Bio’s platform overcomes the core limitations of traditional animal testing, which fails to encapsulate the complexity of human biology. The company is building internal pipelines of novel disease targets and drug candidates in both cancer and autoimmune disease, while collaborating with pharmaceutical companies to evaluate therapies directly in human systems to reduce the cost and risk of clinical trials. Based in San Francisco, the company was founded in 2021 by two of the world’s leading experts in replacing animal models with human-first platforms.
- YC batch
- S21 · Summer 2021
- Status, per YC
- Active
- Category
- AI
- Team size
- 20
- Location
- San Francisco, CA, USA
- Checked
- 1h ago
YC tags: AI-powered Drug Discovery, Biotech
Parallel Bio: questions
Which YC batch was Parallel Bio in?
Parallel Bio was in Y Combinator's Summer 2021 batch (S21).
Is Parallel Bio still active?
Y Combinator lists Parallel Bio as active.
Where is Parallel Bio based?
Parallel Bio lists San Francisco, CA, USA as its location on YC's directory.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.